Document Detail

Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease.
MedLine Citation:
PMID:  16475909     Owner:  NLM     Status:  MEDLINE    
Cardiovascular disease is the leading cause of mortality and morbidity in Western countries. Despite its remarkable medical and social consequences, the prevalence of peripheral arterial disease (PAD) is often underestimated among atherosclerotic disorders. So far, little is known about the behavior of traditional and emerging markers of ischemic heart disease that should allow the reliable identification of PAD patients at increased risk of developing myocardial ischemia and heart failure or dysfunction. To investigate this topic, we measured cardiac troponin T (cTnT), ischemia-modified albumin (IMA) and NT-prohormone-brain natriuretic peptide (NT-proBNP) in 35 consecutive patients with clinically ascertained PAD (stage 2-4, according to Lériche-Fontaine) asymptomatic for chest pain and current heart failure, and 20 controls displaying moderate to high cardiovascular risk factors (hypertension, diabetes, hyperlipidemia), but with no clinical evidence of PAD. Although the concentrations of cTnT and IMA were not statistically increased in PAD patients, NT-pro-BNP values were substantially higher in PAD patients than in controls (62.6 vs. 7.4 pmol/L, p<0.0001). The percentage of subjects displaying values exceeding the specific NT-proBNP diagnostic threshold (>14.8 pmol/L) was also significantly different between PAD patients and controls (74% vs. 10%, p<0.001). After excluding PAD patients exceeding the 0.01 ng/mL cTnT cutoff value indicative of current ischemic cardiac involvement, the median concentration of NT-proBNP remained statistically increased (28.0 vs. 5.8 pmol/L, p<0.0001). Taken together, these results indicate that NT-proBNP, but not IMA, is substantially increased in PAD patients. This finding suggests that such patients, even though asymptomatic, might develop myocardial dysfunction, and thus warrant further investigation.
Martina Montagnana; Giuseppe Lippi; Cristiano Fava; Pietro Minuz; Clara Lechi Santonastaso; Enrico Arosio; Gian Cesare Guidi
Related Documents :
15948099 - Nt-probnp in acute heart failure: correlation with invasively measured hemodynamic para...
10325459 - Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a...
18243859 - Amino-terminal pro-b-type natriuretic peptide testing and prognosis in patients with ac...
18199989 - Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
6496359 - Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin lig...
10364919 - Circulating soluble adhesion molecules in patients with giant cell arteritis. correlati...
17160209 - Familial history of type 2 diabetes in patients from southern brazil and its influence ...
177769 - It's the staff that keeps the patients talking.
23199589 - Taliglucerase alfa leads to favorable bone marrow responses in patients with type i gau...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical chemistry and laboratory medicine : CCLM / FESCC     Volume:  44     ISSN:  1434-6621     ISO Abbreviation:  Clin. Chem. Lab. Med.     Publication Date:  2006  
Date Detail:
Created Date:  2006-02-14     Completed Date:  2006-05-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9806306     Medline TA:  Clin Chem Lab Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  207-12     Citation Subset:  IM    
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Biological Markers / blood
Middle Aged
Myocardial Ischemia / blood,  metabolism*
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood*
Peripheral Vascular Diseases / blood*
Serum Albumin / analysis*
Reg. No./Substance:
0/Biological Markers; 0/Peptide Fragments; 0/Serum Albumin; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell d...
Next Document:  Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activi...